Unity Biotechnology, Inc. (UBX) Stock Analysis
DELISTED
What happened to Unity Biotechnology, Inc. (UBX) stock?
Unity Biotechnology, Inc. (UBX) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $3.44M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Unity Biotechnology, Inc. (UBX). Unity Biotechnology, Inc. is a biotechnology company focused on developing therapeutics for age-related diseases, particularly those affecting the eye.
Last analyzed: May 6, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
Unity Biotechnology, Inc. (UBX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy UBX shares?
No. UBX stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for UBX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before UBX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Unity Biotechnology, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.